Profile | GDS5420 / 215598_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 376.56 | 62 |
GSM1296119 | B_lesional_pre-dose | 271.49 | 57 |
GSM1296076 | C_lesional_pre-dose | 232.78 | 56 |
GSM1296092 | D_lesional_pre-dose | 261.11 | 58 |
GSM1296103 | E_lesional_pre-dose | 483.91 | 67 |
GSM1296078 | F_lesional_pre-dose | 234.56 | 57 |
GSM1296107 | G_lesional_pre-dose | 168.55 | 49 |
GSM1296109 | H_lesional_pre-dose | 302.85 | 58 |
GSM1296080 | I_lesional_pre-dose | 731.43 | 74 |
GSM1296090 | J_lesional_pre-dose | 205.7 | 54 |
GSM1296074 | K_lesional_pre-dose | 368.88 | 64 |
GSM1296111 | L_lesional_pre-dose | 164.46 | 48 |
GSM1296099 | M_lesional_pre-dose | 135.86 | 46 |
GSM1296086 | O_lesional_pre-dose | 250.44 | 57 |
GSM1296117 | P_lesional_pre-dose | 229.44 | 54 |
GSM1296113 | Q_lesional_pre-dose | 180.52 | 48 |
GSM1296096 | R_lesional_pre-dose | 227.33 | 55 |
GSM1296105 | S_lesional_pre-dose | 228.86 | 54 |
GSM1296098 | T_lesional_pre-dose | 332.86 | 61 |
GSM1296101 | U_lesional_pre-dose | 277.03 | 57 |
GSM1296121 | V_lesional_pre-dose | 253.68 | 56 |
GSM1296088 | W_lesional_pre-dose | 291.29 | 59 |
GSM1296082 | X_lesional_pre-dose | 139.63 | 48 |
GSM1296115 | Y_lesional_pre-dose | 150.09 | 47 |
GSM1296084 | Z_lesional_pre-dose | 221.75 | 54 |
GSM1296072 | B_lesional_day8 | 535.36 | 69 |
GSM1296069 | L_lesional_day8 | 191.52 | 50 |
GSM1296071 | P_lesional_day8 | 357.26 | 61 |
GSM1296070 | Y_lesional_day8 | 163.69 | 47 |
GSM1296073 | V_lesional_day8 | 168.54 | 50 |
GSM1296034 | A_lesional_day15 | 567.75 | 69 |
GSM1296041 | G_lesional_day15 | 209.77 | 53 |
GSM1296035 | R_lesional_day15 | 308.81 | 59 |
GSM1296038 | U_lesional_day15 | 221.8 | 54 |
GSM1296047 | B_lesional_day15 | 462.95 | 66 |
GSM1296039 | E_lesional_day15 | 329.71 | 61 |
GSM1296042 | H_lesional_day15 | 255.23 | 55 |
GSM1296043 | L_lesional_day15 | 205.31 | 51 |
GSM1296037 | M_lesional_day15 | 277.62 | 57 |
GSM1296046 | P_lesional_day15 | 372.5 | 62 |
GSM1296044 | Q_lesional_day15 | 290.13 | 57 |
GSM1296045 | Y_lesional_day15 | 278.83 | 57 |
GSM1296025 | C_lesional_day15 | 753.08 | 74 |
GSM1296033 | D_lesional_day15 | 426.33 | 65 |
GSM1296027 | I_lesional_day15 | 471.02 | 67 |
GSM1296032 | J_lesional_day15 | 705.85 | 73 |
GSM1296024 | K_lesional_day15 | 810.86 | 76 |
GSM1296031 | W_lesional_day15 | 395.28 | 63 |
GSM1296028 | X_lesional_day15 | 396.09 | 64 |
GSM1296029 | Z_lesional_day15 | 508.06 | 68 |
GSM1296026 | F_lesional_day15 | 314.31 | 61 |
GSM1296030 | O_lesional_day15 | 386.95 | 64 |
GSM1296040 | S_lesional_day15 | 341.32 | 61 |
GSM1296036 | T_lesional_day15 | 424.41 | 64 |
GSM1296048 | V_lesional_day15 | 212.12 | 53 |
GSM1296059 | A_lesional_day43 | 268.19 | 58 |
GSM1296066 | G_lesional_day43 | 244.69 | 55 |
GSM1296060 | R_lesional_day43 | 290.17 | 58 |
GSM1296063 | U_lesional_day43 | 168.41 | 49 |
GSM1296064 | E_lesional_day43 | 235.15 | 56 |
GSM1296067 | H_lesional_day43 | 380.49 | 62 |
GSM1296062 | M_lesional_day43 | 244.13 | 55 |
GSM1296068 | Q_lesional_day43 | 209.5 | 51 |
GSM1296050 | C_lesional_day43 | 442.63 | 66 |
GSM1296057 | D_lesional_day43 | 436.27 | 65 |
GSM1296052 | I_lesional_day43 | 418.02 | 65 |
GSM1296054 | J_lesional_day43 | 614.68 | 71 |
GSM1296049 | K_lesional_day43 | 807.33 | 76 |
GSM1296055 | W_lesional_day43 | 310.03 | 59 |
GSM1296053 | X_lesional_day43 | 401.15 | 64 |
GSM1296058 | Z_lesional_day43 | 401.86 | 64 |
GSM1296051 | F_lesional_day43 | 282.23 | 59 |
GSM1296056 | O_lesional_day43 | 313.95 | 61 |
GSM1296065 | S_lesional_day43 | 269.78 | 57 |
GSM1296061 | T_lesional_day43 | 280.43 | 57 |
GSM1296095 | A_non-lesional_pre-dose | 305.3 | 60 |
GSM1296120 | B_non-lesional_pre-dose | 424.98 | 65 |
GSM1296077 | C_non-lesional_pre-dose | 792.25 | 75 |
GSM1296093 | D_non-lesional_pre-dose | 629.17 | 71 |
GSM1296104 | E_non-lesional_pre-dose | 359.37 | 62 |
GSM1296079 | F_non-lesional_pre-dose | 741.72 | 74 |
GSM1296108 | G_non-lesional_pre-dose | 370.12 | 62 |
GSM1296110 | H_non-lesional_pre-dose | 419.77 | 64 |
GSM1296081 | I_non-lesional_pre-dose | 570.62 | 70 |
GSM1296091 | J_non-lesional_pre-dose | 400.39 | 64 |
GSM1296075 | K_non-lesional_pre-dose | 585.39 | 71 |
GSM1296112 | L_non-lesional_pre-dose | 370.71 | 62 |
GSM1296100 | M_non-lesional_pre-dose | 326.64 | 60 |
GSM1296087 | O_non-lesional_pre-dose | 487.51 | 68 |
GSM1296118 | P_non-lesional_pre-dose | 515.06 | 68 |
GSM1296114 | Q_non-lesional_pre-dose | 324.87 | 60 |
GSM1296097 | R_non-lesional_pre-dose | 324.84 | 60 |
GSM1296106 | S_non-lesional_pre-dose | 366.38 | 62 |
GSM1296102 | U_non-lesional_pre-dose | 387.53 | 62 |
GSM1296122 | V_non-lesional_pre-dose | 388.98 | 63 |
GSM1296089 | W_non-lesional_pre-dose | 375.34 | 62 |
GSM1296083 | X_non-lesional_pre-dose | 451.34 | 66 |
GSM1296116 | Y_non-lesional_pre-dose | 252.62 | 54 |
GSM1296085 | Z_non-lesional_pre-dose | 484.17 | 67 |